Condition
Elevated Prostate Specific Antigen
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Recruiting2
Unknown1
Terminated1
Clinical Trials (4)
Showing 4 of 4 trials
NCT03474913Recruiting
Upright MRI for Prostate Cancer Screening
NCT04599218Not ApplicableRecruiting
MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer
NCT04026763Not ApplicableUnknown
MR/TRUS Fusion Guided Prostate Biopsy
NCT00840294Phase 3TerminatedPrimary
Randomized Trial of Ciprofloxacin Versus Observation for Men With Elevated Prostate Specific Antigen (PSA)
Showing all 4 trials